Related Experiment Video
Updated: Jan 13, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
Precision Nanotechnology: Revolutionizing Therapeutic Strategies Against Drug-Resistant Breast Cancer
ZahraSadat Razavi1, Arefeh Mottaghi2, Lyudmila Dmitrieva3
1Physiology Research Center, Iran University Medical Sciences, Tehran, Iran. Farnaz.razavi@iau.ir.
Abstract:
Drug resistance, which arises from a variety of biological mechanisms such as drug efflux by ATP-binding cassette transporters, epithelial-to-mesenchymal transition (EMT), the presence of cancer stem cells (CSCs), immune system evasion, and changes in the tumor microenvironment (TME), poses serious treatment challenges for breast cancer. This paper offers a thorough analysis of various resistance mechanisms, going into great detail into the molecular, cellular, and genetic contributors. We next look at how nanotechnology-based approaches, such multifunctional nanocarriers, smart nanoparticle systems, and targeted drug delivery, can be developed to get around these resistance mechanisms, building on this biological basis. The use of particular nanotechnology platforms (such as liposomes, micelles, and dendrimers) to target CSCs, circumvent efflux pumps, alter immunological responses, and improve treatment precision is highlighted. Important issues in clinical translation and regulatory considerations are also covered in the study. This two-part investigation seeks to improve therapeutic outcomes for drug-resistant breast cancer by bridging the gap between molecular insight and nanotechnological innovation.
Insights
This study explores breast cancer drug resistance mechanisms like efflux pumps and cancer stem cells. Nanotechnology offers novel strategies to overcome resistance, improving treatment outcomes.
Area of Science:
- Oncology
- Nanomedicine
- Biotechnology
Background:
- Breast cancer drug resistance presents significant challenges due to mechanisms like ATP-binding cassette transporters, epithelial-to-mesenchymal transition (EMT), cancer stem cells (CSCs), immune evasion, and tumor microenvironment (TME) alterations.
- Understanding the molecular, cellular, and genetic underpinnings of these resistance mechanisms is crucial for developing effective therapeutic strategies.
Purpose of the Study:
- To comprehensively analyze the multifaceted mechanisms of breast cancer drug resistance.
- To investigate the potential of nanotechnology-based approaches in overcoming these resistance mechanisms.
- To bridge the gap between molecular insights into resistance and nanotechnological innovations for improved therapeutic outcomes.
Main Methods:
- Detailed analysis of molecular, cellular, and genetic contributors to drug resistance.
- Exploration of nanotechnology platforms including multifunctional nanocarriers, smart nanoparticle systems, and targeted drug delivery.
- Evaluation of specific nanocarriers like liposomes, micelles, and dendrimers for targeting CSCs and circumventing resistance pathways.
Main Results:
- Identification of key biological mechanisms driving breast cancer drug resistance.
- Demonstration of how nanotechnology can be engineered to target CSCs, bypass efflux pumps, modulate immune responses, and enhance treatment precision.
- Highlighting the application of liposomes, micelles, and dendrimers in overcoming specific resistance challenges.
Conclusions:
- Nanotechnology holds significant promise for overcoming diverse breast cancer drug resistance mechanisms.
- Targeted delivery systems and advanced nanocarriers can enhance therapeutic efficacy against resistant breast cancer.
- Further research and consideration of clinical translation and regulatory aspects are essential for implementing these nanotechnological innovations.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistant Cancers

